Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Biological & Pharmaceutical Bulletin|September 4, 2023
Therapeutic Effect of Colony Stimulating Factor 1 Receptor Kinase Inhibitor, JTE-952, on Methotrexate-Refractory Pathology in a Rat Model of Rheumatoid ArthritisNaofumi Uesato, Yoshihiro Kitagawa, Yushi Matsuo, et al.Surgery|April 23, 2013
Inhibition of CCL20 increases mortality in models of mouse sepsis with intestinal apoptosisYoshihiro Kitagawa, Shojiro Kikuchi, Yoshihisa Arita, et al.Behavioural Brain Research|October 2, 2024
Automated analysis of a novel object recognition test in mice using image processing and machine learningTakuya Kishi, Koji Kobayashi, Kazuo Sasagawa, et al.The Journal of Urology|September 25, 2012
JTS-653 blocks afferent nerve firing and attenuates bladder overactivity without affecting normal voiding functionYoshihiro Kitagawa, Masashi Wada, Tomokazu Kanehisa, et al.Biological & Pharmaceutical Bulletin|December 3, 2020
JTE-952 Suppresses Bone Destruction in Collagen-Induced Arthritis in Mice by Inhibiting Colony Stimulating Factor 1 ReceptorNaofumi Uesato, Koji Inagaki, Naoki Miyagawa, et al.Biological & Pharmaceutical Bulletin|February 4, 2020
Pharmacological Properties of JTE-952, an Orally Available and Selective Colony Stimulating Factor 1 Receptor Kinase InhibitorNaofumi Uesato, Naoki Miyagawa, Koji Inagaki, et al.Diabetes Care|May 27, 2003
Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetesMichiaki Fukui, Yoshihiro Kitagawa, Naoto Nakamura, et al.Immunology Letters|July 13, 2005
Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylaseMichiyo Ishii, Goji Hasegawa, Michiaki Fukui, et al.The Journal of Pharmacology and Experimental Therapeutics|May 17, 2012
Pharmacological characterization of (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide (JTS-653), a novel transient receptor potential vanilloid 1 antagonistYoshihiro Kitagawa, Atsuko Miyai, Kenji Usui, et al.Rinsho Byori. the Japanese Journal of Clinical Pathology|December 31, 2013
[Contribution of clinical laboratory to the diabetes care team: efforts in physiological laboratory]Yasuhiro Komiyama, Kouji Fujita, Keiko Ikeda, et al.Pageof 4